BMRN Biomarin Pharmaceutical Inc

Biomarin Pharmaceutical Inc is on rare-disease therapies. It develops and commercializes pharmaceuticals for serious diseases and medical conditions.

$75.60  -0.09 (-0.12%)
As of 05/12/2021 16:00:00 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Large cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  02/06/2001
Outstanding shares:  182,742,573
Average volume:  835,346
Market cap:   $13,959,705,151
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    09061G101
ISIN:        US09061G1013
Sedol:      2437071
Valuation   (See tab for details)
PE ratio:   17.40
PB ratio:   3.32
PS ratio:   7.57
Return on equity:   19.10%
Net income %:   43.11%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy